Partnership leverages AI-powered genome design to optimize AAV constructs, accelerate lead candidate selection, and improve drug substance manufacturability for rare and ultra-rare neuromuscular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback